NanoSyrinx

Nanograb

This company develops an artificial intelligence platform to design targeted gene delivery vectors and nanoparticles for pharmaceutical organisations developing genetic medicines.

Breeze

This company develops polymer nanoparticles to enable the non-viral delivery of RNA therapeutics to extrahepatic tissues for biotechnology and pharmaceutical organisations.

Optimeos Life Sciences

This company develops nanoparticle drug delivery systems and long-acting injectables for pharmaceutical partners to enable targeted intracellular delivery of genetic medicines and proteins.

Nuntius Therapeutics

This company develops mRNA and gene-editing therapies using a programmable nanocarrier delivery platform for pharmaceutical companies and research institutions.

Theraport

Theraport develops engineered exosomes to facilitate the targeted delivery of drugs and genetic medicines for patients with complex diseases.

NaDeNo

This company develops a nanotechnology drug delivery platform for pharmaceutical partners to encapsulate hydrophobic small molecule drugs for targeted cancer treatments.

Nanite

Nanite develops programmable polymer nanoparticles for non-viral gene delivery to support genetic medicine companies and patient advocacy groups.

Nanoligent

The company develops targeted protein-drug nanoconjugates for oncology patients to treat metastatic tumours by selectively eliminating cells overexpressing the CXCR4 receptor.